SMEP
17.1.2024 10:57:28 CET | Business Wire | Press release
Saudi Arabia reinforced its call for an immediate ceasefire in Gaza, and an end to the spiraling volatility in the Red Sea, today at the World Economic Forum (WEF) Annual Meeting 2024.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240116473725/en/
Saudi Arabia reiterates call for immediate ceasefire in Gaza at the World Economic Forum Annual Meeting 2024 (Photo: AETOSWire)
Speaking at a session on ‘Securing an Insecure World’, Saudi Arabia’s Minister of Foreign Affairs, His Highness Prince Faisal bin Farhan bin Abdullah, said: “We need to focus on the immediate crisis which is the suffering that is happening in Gaza.
“The international community has been moving more in the direction that we have called for since the beginning, which is a ceasefire and more humanitarian aid. But we need to do more. We agree that regional peace includes peace for Israel, but that can only happen through peace for the Palestinians, through a Palestinian state.”
On the escalating volatility in the Red Sea, His Highness added: “Freedom of navigation in the Red Sea is something that impacts all of us, and the priority needs to be de-escalation.”
During a panel session on “Frictionless Services”, His Excellency Dr. Majid A. Alkassabi, Minister of Commerce, described the speed and scale of Saudi Arabia’s economic diversification, saying The Kingdom “has revamped over 200 laws and bylaws to make the business environment attractive.”
His Excellency Adel A. Aljubeir, Minister of State for Foreign Affairs, Member of the Council of Ministers, and Envoy for Climate, Member of the Council of Ministers and Envoy for Climate Affairs reiterated the need for substantive global collaboration to tackle the climate crisis, saying, “unless we work together, we are going to achieve nothing,” in a session as part of the new Saudi House: Bold Visions Series – the Kingdom’s pavilion connecting policymakers and innovators.
In ‘Gulf Economies: All In,’ His Excellency Khalid A. Al Falih, Minister of Investment, shared his optimistic outlook for the Gulf, noting how “the GCC is attracting FDI at more than twice the average rate than around the world when you compare it and normalize it for GDP. We believe we are at inflection point of increase of FDI, as we have seen in Saudi Arabia.”
In a session on ‘Regulating Non-Banks’, His Excellency Mohammed Aljadaan, Minister of Finance, warned governments not to “kill innovation” and deprive the private sector from investment opportunities by applying blanket regulatory frameworks to banks and non-regulated financial institutions, alike.
In a session on ‘AI: The Great Equaliser’, His Excellency Abdullah A. Alswaha, Minister of Communications and Information Technology, said the Kingdom’s consistency on being “pro-innovation, pro-partnership” has harnessed emerging technologies like Generative AI to build a human-centric future.
His Excellency Bandar I. Alkhorayef, Minister of Industry and Mineral Resources, highlighted Saudi Arabia’s “three dimensional” policy approach to building industrial capabilities and creating an investor-friendly environment to unlock the untapped potential of Saudi Arabia’s vast mineral assets.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240116473725/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom